Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Economics Highlights: Doc agrees to pay $5M | A new class-action lawsuit | Colchicine for CVD: What will it cost?
Friday, June 30, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Economics

Cardiologist agrees to pay $5M for overstating heart findings to justify unnecessary procedures

The North Carolina physician allegedly performed unnecessary atherectomy procedures to treat minor blockages in the leg arteries of multiple patients.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist agrees to pay $5M for overstating heart findings to justify unnecessary procedures

Share on Twitter Share on Facebook Share on Linkedin
The North Carolina physician allegedly performed unnecessary atherectomy procedures to treat minor blockages in the leg arteries of multiple patients.
READ MORE >

Cardiologists earn the highest annual salary in 2 states

According to new data out of the U.S. Department of Labor, physicians have the highest-paying jobs in a majority of states. Cardiologists specifically rank No. 1 in two different states. 

READ MORE >
cardiologist patient heart compensation starting salary 2022 interventional cardiologist
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists earn the highest annual salary in 2 states

Share on Twitter Share on Facebook Share on Linkedin
cardiologist patient heart compensation starting salary 2022 interventional cardiologist
According to new data out of the U.S. Department of Labor, physicians have the highest-paying jobs in a majority of states. Cardiologists specifically rank No. 1 in two different states. 
READ MORE >

Cardiology group faces class-action lawsuit after cyberattack exposed patients’ personal data

Patients learned that their names, social security numbers, banking numbers and credit card information were all potentially exposed as a result of the attack.

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

Cardiology group faces class-action lawsuit after cyberattack exposed patients’ personal data

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
Patients learned that their names, social security numbers, banking numbers and credit card information were all potentially exposed as a result of the attack.
READ MORE >

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD

“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business. 

READ MORE >
Colchicine Lodoco Agepha Pharma price cost cardiovascular disease CVD
Share on Twitter Share on Facebook Share on Linkedin

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD

Share on Twitter Share on Facebook Share on Linkedin
Colchicine Lodoco Agepha Pharma price cost cardiovascular disease CVD
“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business. 
READ MORE >

Cardiologist ordered to pay $2.6M after foreign material left in patient’s femoral artery

The patient's leg remains disfigured years after the incident. 

READ MORE >
The long legal saga of Richard Paulus, a Kentucky cardiologist accused of performing unnecessary cardiac procedures, appears to still be going strong in 2022 and might be reviewed by the Supreme Court. The New York state radiologist is facing 36 misdemeanor counts for secret sexual recording without consent, according to a story in the Boston Herald.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist ordered to pay $2.6M after foreign material left in patient’s femoral artery

Share on Twitter Share on Facebook Share on Linkedin
The long legal saga of Richard Paulus, a Kentucky cardiologist accused of performing unnecessary cardiac procedures, appears to still be going strong in 2022 and might be reviewed by the Supreme Court. The New York state radiologist is facing 36 misdemeanor counts for secret sexual recording without consent, according to a story in the Boston Herald.
The patient's leg remains disfigured years after the incident. 
READ MORE >

Private equity-backed cardiology group acquires ‘world-class' practice with team of 23 cardiologists

This latest acquisition continues what has been a busy year for Cardiovascular Associates of America. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Private equity-backed cardiology group acquires ‘world-class' practice with team of 23 cardiologists

Share on Twitter Share on Facebook Share on Linkedin
This latest acquisition continues what has been a busy year for Cardiovascular Associates of America. 
READ MORE >

Conformal Medical raises $35M to continue development, research of next-gen LAAO device

The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.

READ MORE >
The CLAAS device from Conformal Medical. The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.
Share on Twitter Share on Facebook Share on Linkedin

Conformal Medical raises $35M to continue development, research of next-gen LAAO device

Share on Twitter Share on Facebook Share on Linkedin
The CLAAS device from Conformal Medical. The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.
The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.
READ MORE >

Nearing a ‘breaking point’: Cardiologists support legislation designed to mitigate Medicare cuts to office-based services

These latest cuts could be a "breaking point" for physicians, according to a new letter to lawmakers. 

READ MORE >
Medicare money payment
Share on Twitter Share on Facebook Share on Linkedin

Nearing a ‘breaking point’: Cardiologists support legislation designed to mitigate Medicare cuts to office-based services

Share on Twitter Share on Facebook Share on Linkedin
Medicare money payment
These latest cuts could be a "breaking point" for physicians, according to a new letter to lawmakers. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI making an impact behind the scenes | New EARLY TAVR data | Americans keep poisoning themselves with semaglutide
Week in Review: TAVR vs. SAVR | FDA clears AI tech | Payment model confusion | Private equity & cardiology | Injuries after PCI
Heart surgery kits recalled | Sex-specific outcomes after TAVR & SAVR | A new risk calculator | FDA clears tricuspid valve
Thousands of heart surgery kits recalled | TAVR for AR linked to 'encouraging' data | Carotid IVL | Progress for new HCM drug
AI company founded by cardiologist makes big splash | Getting clinicians on the same page | Kidney injuries after PCI
Sweeping TAVR changes on the way | Pushing back against AI-powered prior authorization | FDA highlights recall after injuries
Cardiologists added to payment model by mistake | Sex-specific outcomes after TAVR & SAVR | FDA clears new AI software

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup